Why Is It So Hard To Get Opioid Refills? A Neurosurgeon Explains

Opioid medication has long been associated with a significant stigma due to the risks of dependency and abuse. However, for certain patients recovering from spine surgery, these medications are a necessary part of their pain management regimen. In the United States, accessing opioid medications for legitimate pain management has become increasingly challenging, even for patients undergoing invasive spine reconstruction surgery. The layers of bureaucracy, stigma, and caution surrounding opioid prescriptions have intensified in efforts to combat the opioid epidemic, which has led to hundreds of thousands of deaths primarily from overdoses.

Despite a significant decrease in opioid prescriptions since the early 2010s, overdose rates have not fallen proportionally. This discrepancy highlights the need to strike a balance between implementing safety measures and meeting the genuine needs of patients suffering from chronic conditions, post-surgical pain, or terminal illnesses.

Patients who require opioids for pain management face numerous obstacles, including frequent doctor visits for limited quantities, strict refill limitations, and sudden dosage adjustments. Many chronic pain patients report difficulty obtaining prescriptions, which can lead to severe withdrawal symptoms, psychological distress, and, in extreme cases, suicidal ideation. The pervasive stigma surrounding opioid use contributes to patient abandonment and challenges in long-term management.

Clinicians also face challenges in prescribing opioids, including fear of regulatory investigations, mandatory Prescription Drug Monitoring Program checks, prior authorizations, and time constraints. The reduction in opioid prescriptions has not effectively reduced overdose rates, as illicit fentanyl now contributes to the majority of overdose deaths. Desperate patients may turn to street drugs after being cut off from pain management by healthcare providers.

The opioid crisis originated from aggressive marketing, relaxed prescribing norms, and the push to treat pain as the “fifth vital sign.” In response, guidelines were issued to limit initial prescriptions and promote non-opioid alternatives. However, these restrictions have shifted the burden to patients and healthcare providers.

Moving forward, a balanced approach to opioid medication should prioritize non-opioid therapies, shared decision-making, and flexibility in prescribing. Reforming regulations and electronic prescribing hurdles can ensure timely access to opioids for those in need while reducing the risk of misuse. Comprehensive treatment for opioid use disorder and clinician education are essential components of a multifaceted approach to opioid management.

Ultimately, the goal should be to provide ethical, prudent, and compassionate care that meets the needs of patients while mitigating the risks associated with opioid use. By prioritizing patient-centered care and personalized treatment plans, we can work towards a safer and more effective approach to opioid medication.